Class Action

Class Action Law360 provides breaking news and analysis on class actions and multidistrict litigation. Coverage includes developments in multiparty litigation in federal and state courts, as well as policy issues and court rulings that affect class action procedure.



Sign up for a 7-day FREE trial today!



Latest News in Class Action

  • July 16, 2026

    Pa. Hospital Must Face Bulk Of Website Pixel Tracking Row

    A Pennsylvania federal judge has mostly refused to toss a putative class action accusing Warren General Hospital of illegally deploying tracking technology that divulged website visitors' private health information to Meta and others, trimming injunctive relief and negligence per se allegations while allowing state wiretap and six other claims to proceed.

  • July 16, 2026

    Meta Can't Keep Certain Docs Secret In DC Social Media Row

    Washington, D.C.'s highest court refused to make a trial court vacate discovery orders requiring Meta to disclose certain communications concerning internal research related to the well-being of young social media users, saying Thursday that Meta failed to show it had a "clear and indisputable" right to such relief.

  • July 16, 2026

    Mo. Pot Co. Monopoly Suit Belongs In State Court, Buyer Says

    Cannabis company Good Day Farm Retail Management has allegedly become an illegal monopoly in Missouri, capturing more than a quarter of the state's available dispensary licenses through an ownership and management scheme, according to a lawsuit by a consumer who seeks to push the case back into state court.

  • July 16, 2026

    Apple, Amazon Face Bid To Revive Wash. Antitrust Suit

    Plaintiffs' counsel urged a Seattle federal judge Thursday to rethink dismissal of a proposed antitrust class action accusing Apple and Amazon of illegally restricting sales of iPhones and iPads, contending that attorneys at Hagens Berman couldn't have concluded from their client's "ambiguous" message that he wanted to get out of the case.

  • July 16, 2026

    Pharma Co. Beats Investor Suit Over Prostate Drug Trial

    A Wisconsin federal judge ruled Wednesday that investors of prostate cancer treatment developer Essa Pharma Inc. have not shown they were misled by the company on the efficacy of its lead drug candidate, which was not as effective as an existing treatment for certain cancer patients in a terminated clinical trial.

See more Class Action news

Class action

Areas of Coverage

  • LITIGATION
  • Putative class action complaints
  • Class certification and decertification motions and orders
  • Certification appeals
  • Class settlements
  • Case rulings and appeals
  • Collective actions
  • Multidistrict litigation
  • Shareholder actions
  • Disputes over counsel and attorneys fees in multiparty litigation
  • Expert witness disputes
  • POLICY & REGULATION
  • Federal and state regulation and legislation affecting class action procedure
  • PROFILES
  • Personnel moves
  • Profiles of class action practices

Readership

  • Class action lawyers at top law firms
  • Corporate counsel and compliance officers at Fortune 1000 companies
  • Information experts at law firms, agencies, and companies
  • Policymakers at federal and state agencies
  • Judges and court staff across the U.S.
  • Professors, students, and library staff at every accredited law school in the U.S.
  • Attorney and law firm marketing professionals